Yi Yong Baek

Title: Yi Yong Baek: Innovator in Angiogenesis Research

Introduction

Yi Yong Baek is a prominent inventor based in Goyang-si, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of peptides for inhibiting angiogenesis. With a total of seven patents to his name, Baek's work focuses on innovative solutions for treating diseases related to excessive angiogenesis.

Latest Patents

Among his latest patents is a composition for preventing and treating angiogenesis-related diseases. This includes improved peptides such as Ac-RLYE and R(D)LYE, which serve as active ingredients in compositions aimed at cancer prevention and treatment. These peptides have been shown to possess a long half-life and exhibit excellent inhibitory effects on VEGF-induced angiogenesis. Another notable patent involves a fusion protein bound to cell-permeable peptides, which enhances skin permeability and is useful for treating wrinkles and wounds.

Career Highlights

Yi Yong Baek is currently associated with Avixgen Inc., where he continues to advance his research in peptide technology. His innovative approaches have positioned him as a key figure in the field of angiogenesis research. His work not only contributes to scientific knowledge but also has practical applications in medicine.

Collaborations

Baek collaborates with notable colleagues such as Hye Cheong Koo and Jun Sub Choi. These partnerships enhance the research capabilities and foster innovation within their projects.

Conclusion

Yi Yong Baek's contributions to the field of angiogenesis research through his innovative patents and collaborations highlight his role as a leading inventor. His work has the potential to significantly impact the treatment of diseases related to angiogenesis.